Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Overview

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double
  • Study Primary Completion Date: November 2001

Interventions

  • Drug: brimonidine/timolol fixed combination

Clinical Trial Outcome Measures

Primary Measures

  • IOP

Participating in This Clinical Trial

Inclusion Criteria

  • Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes – Patient requires IOP-lowering drug in both eyes Exclusion Criteria:

  • Uncontrolled medical condition – Contraindication to beta-adrenoceptor antagonist or brimonidine therapy

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Allergan
  • Provider of Information About this Clinical Study
    • Therapeutic Area Head, Allergan, Inc

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.